tiprankstipranks
Shield Therapeutics PLC (GB:STX)
LSE:STX
UK Market
Want to see GB:STX full AI Analyst Report?

Shield Therapeutics (STX) Technical Analysis

41 Followers

Technical Sentiment

Overall Consensus
Sell
4Bullish
5Neutral
13Bearish
Technical Analysis Consensus
Sell
2Bullish
5Neutral
3Bearish
Moving Average Consensus
Strong Sell
2Bullish
0Neutral
10Bearish
Shield Therapeutics PLC’s (STX) Moving Averages Convergence Divergence (MACD) indicator is -0.13, suggesting Shield Therapeutics PLC is a Sell.
Shield Therapeutics PLC’s (STX) 20-Day exponential moving average is 6.26, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) 50-Day exponential moving average is 6.76, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.

Shield Therapeutics (STX) Pivot Points

Jul 06, 2026, 04:50 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
5.43
5.62
5.83
6.02
6.23
6.42
6.63
Fibonacci
5.62
5.77
5.86
6.02
6.17
6.26
6.42
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Shield Therapeutics (STX) Moving Averages

Jul 06, 2026, 04:50 AM
Period
Simple
Exponential
MA5
6.14Buy
6.14Buy
MA10
6.22Sell
6.19Sell
MA20
6.25Sell
6.26Sell
MA50
6.68Sell
6.76Sell
MA100
7.88Sell
7.44Sell
MA200
8.46Sell
7.55Sell
Shield Therapeutics PLC’s (STX) 10-Day exponential moving average is 6.19, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) 100-Day exponential moving average is 7.44, while Shield Therapeutics PLC’s (STX) share price is 9.85 p, making it a Sell.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 50-day simple moving average is 6.68, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 100-day simple moving average is 7.88, creating a Sell signal.
Shield Therapeutics PLC’s (STX) stock price is 9.85 p and Shield Therapeutics PLC’s (STX) 200-day simple moving average is 8.46, creating a Sell signal.

Shield Therapeutics (STX) Technical Indicators

Jul 06, 2026, 04:50 AM
Name
Value
Implied Action
RSI (14)
43.01
Neutral
STOCH (9,6)
29.37
Neutral
STOCHRSI (14)
29.37
Neutral
MACD (12,26)
-0.13
Sell
ADX (14)
17.15
Buy
Williams %R
-61.11
Buy
CCI (14)
-65.20
Neutral
ATR (14)
0.35
-
Ultimate Oscillator
54.23
Neutral
ROC
-3.91
Sell
Shield Therapeutics PLC’s (STX) Relative Strength Index (RSI) is 43.01, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Trend Strength Indicator (ADX) is 17.15, creating a Buy signal.
Shield Therapeutics PLC’s (STX) Commodity Channel Index (CCI) is -65.20, creating a Neutral signal.
Shield Therapeutics PLC’s (STX) Price Rate of Change (ROC) is -3.91, creating a Sell signal.

FAQ

Is STX a Buy, Hold, or Sell?
Based on STX’s technical indicators, STX is a Sell.
    What is STX’s RSI (14)?
    STX’s RSI (14) is 43.01, which suggests STX is a Neutral.
      What is STX’s MACD?
      STX’s MACD is -0.13, which suggests STX is a Sell.
        What is STX’s 5-day moving average?
        STX’s 5-day moving average is 6.14, which suggests STX is a Buy.
          What is STX’s 20-day moving average?
          STX 20-day moving average is 6.25, which suggests STX is a Sell.
            What is STX’s 50-day moving average?
            STX’s 50-day moving average is 6.68, which suggests STX is a Sell.
              What is STX’s 200-day moving average?
              STX’s 200-day moving average is 8.46, which suggests STX is a Sell.
                What is STX’s Williams % R (14)?
                STX’s Williams % R (14) is -61.11, which suggests STX is a Buy.
                  What is STX’s CCI (14)?
                  STX’s CCI (14) is -65.20, which suggests STX is a Neutral.
                    What is the share price of Shield Therapeutics PLC?